News
7mon
Live Science on MSN10 'superbug' stories from 2024, from bacterial 'Kryptonite' to deep-sea antibiotics
Antibiotic and antifungal drug resistance pose a major public health threat. Live Science is covering the spread of this ...
Indeed, two reports published in 2018 and 2019 by the Ohio Department of Health, that also studied Carbapenem-resistance, found the incidence of Carbapenem-resistant bacterial infections in ...
To determine the effect of antibiotics, the team tested them on samples of human faeces in the lab, alongside experiments in mice and lab tests of carbapenem-resistant Enterobacteriaceae (CRE).
11mon
Live Science on MSN10 of the deadliest superbugs that scientists are worried about
These bacteria have evolved the ability to resist treatment with antibiotics, leaving doctors scrambling to help patients who ...
To determine the effect of antibiotics, the team tested them on samples of human feces in the lab, alongside experiments in mice and lab tests of carbapenem-resistant Enterobacteriaceae (CRE).
Carbapenem-resistant A. baumannii is a type of gram-negative bacteria, a vexing category of superbugs. Encased in both an inner and outer membrane that antibiotics struggle to cross, gram-negative ...
Antibiotics promote intestinal growth of carbapenem-resistant Enterobacteriaceae by enriching nutrients and depleting microbial metabolites. Nature Communications, 2023; 14 (1) DOI: 10.1038/s41467 ...
An oral antibiotic treatment with nonabsorbable drugs may help eradicate Carbapenem-resistant Enterobacteriaceae colonization, according to a study published in the American Journal of Infection ...
Increasing incidence of bloodstream infections with Enterobacterales resistant to carbapenem antibiotics poses a significant threat to patients and healthcare systems in the EU/EEA Furthermore ...
The study revealed CRE in children is still fairly rare, but the rate of infection has increased significantly among children of all ages and settings, from zero percent in 1999 to 2000, to 0.47 ...
Only seven new systemic antibiotics were approved for marketing by the Food and Drug Administration (FDA) between 1998 and 2002, four between 2003 and 2007, and two between 2008 and 2010. [1] ...
American Journal of Health-System Pharmacy Doripenem: A New Carbapenem Antibiotic Elias B. Chahine; Mary J. Ferrill; Mara N. Poulakos Disclosures Am J Health Syst Pharm. 2010;67 (23):2015-2024. 0 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results